Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2026-01-01 @ 6:03 AM
Study NCT ID:
NCT02846532
Status:
COMPLETED
Last Update Posted:
2025-03-30
First Post:
2016-07-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-16
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-25
First Submit QC Date:
None
Study First Post Date:
2016-07-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-13
Results First Submit QC Date:
None
Results First Post Date:
2022-03-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-07-16
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-03-28
Last Update Post Date:
2025-03-30
Last Update Post Date Type:
ACTUAL